HomePortfoliosDickran XTB Final

Dickran XTB Final

Optimize
None Rebalancing
USD
Moderate Risk
2.6yr backtest

Performance Summary

Total Return+110.78%
Annualized Return+33.86%
Volatility+15.67%
Sharpe Ratio2.03
Max Drawdown+18.53%

Holdings

Asset Allocation

Asset Class

Equity 100.0%
Holdings Details
Diversified global equity portfolio with core S&P 500, Nasdaq 100, and targeted factor ETFs for growth, value, and momentum exposure.
AssetTypeAllocationTER
SPYL.LSE
SPDR S&P 500 UCITS ETF (Acc)IE000XZSV718
ETF
40.0%0.03%
IWVL.LSE
iShares Edge MSCI World Value Factor UCITS ETFIE00BP3QZB59
ETF
25.0%0.25%
XNAS.LSE
Xtrackers Nasdaq 100 UCITS ETF 1CIE00BMFKG444
ETF
20.0%0.2%
IWMO.LSE
iShares Edge MSCI World Momentum Factor UCITS ETF (Acc)IE00BP3QZ825
ETF
10.0%0.25%
SMH.LSE
VanEck Semiconductor UCITS ETFIE00BMC38736
ETF
5.0%0.35%
Total100.0%0.16%

Performance

Portfolio Value Over Time
Starting with $10,000 investment → now worth $21,077.77
Histogram of Monthly Returns
The portfolio had a positive return during 23 of the 32 months (72%)
Monthly Returns Heatmap
Best month: +15.9% • Worst month: -7.5% • Best year: 2025 (+25.0%) • Worst year: 2023 (+15.7%)
YearJanFebMarAprMayJunJulAugSepOctNovDecTotal
2026+3.5%+0.2%-7.5%+15.9%+8.2%-------+20.3%
2025+3.4%-2.9%-4.9%+0.5%+7.6%+5.5%+2.1%+1.9%+4.1%+4.0%-0.0%+1.8%+25.0%
2024+2.0%+4.2%+3.9%-3.5%+3.3%+4.9%-0.1%+0.8%+2.3%-1.1%+4.0%-1.0%+21.1%
2023---------+0.0%+9.2%+6.0%+15.7%
> +2%
0% to +2%
-2% to 0%
< -2%
Drawdown Analysis
Maximum drawdown: +18.53% • The longest drawdown period lasted for 3 months and was between February 2025 and June 2025. It reached a trough of -18.5%.

Detailed Metrics

Returns
Total Return
+110.78%
Annualized Return
+33.86%
Avg Monthly Return
+2.45%
Risk
Volatility (Annual)
+15.67%
Max Drawdown
+18.53%
Positive Months
72%
Average Drawdown
-2.4%
Risk-Adjusted
Sharpe Ratio
2.03
Risk-free rate: 2.0%
Sortino Ratio
1.97
Downside risk adjusted
Return/Volatility
2.16
Calmar Ratio
1.83
Return/Max Drawdown
Ulcer Index
3.29
Drawdown depth & duration
Martin Ratio
0.10
Return/Ulcer Index
Backtest Configuration
Initial Investment
$10,000
Final Value
$21,077.77
Backtest Period
2023-10-31 to 2026-05-22
2.6 years
Rebalancing
none
Base Currency
USD